Current Research: Cagrilintide, an amylin analog. Amylin is a hormone co-secreted with insulin that helps regulate glucose levels and suppress appetite. Cagrilintide mimics amylin’s effects, enhancing satiety and reducing food intake. By combining Cagrilintide with Semaglutide, CagriSema, researchers aim to provide a more rapid and comprehensive approach to menopausal fat belly loss by targeting multiple pathways involved in appetite regulation and glucose metabolism.

Size: 1gram/1000mg

Class: Injectable grade sublingual/oralbuccal peptide with 99.9% purity, with comparable bioavailability as injections. Available in tablet, capsule, sublingual lyophilized powder, and liquid formats.